Sickle cell anemia patients suffer end organ damage due to vaso-occlusion. Over the past two decades investigations of red blood cell/vessel wall interactions have led to a revised paradigm for the understanding of vaso-occlusive phenomena in sickle cell disease. Clinical conditions associated with inflammation such as infections, surgery and others exacerbate crises in sickle cell anemia patients. Preliminary data demonstrate that patients with sickle cell disease have markers of inflammation including elevated C-reactive protein levels and activated monocytes. In vitro these monocytes activate human endothelial cell NF-kB and adhesion molecule expression. Transgenic mouse models of human sickle cell disease also have markers of inflammation, including elevated white blood cell counts and activated monocytes. This proposal posits that an inflammatory phenotype augments tissue injury through worsened vasoocclusion. Thus, inflammation augments vaso-occlusion while anti-inflammatory agents may minimize vaso-occlusion. The project will examine these hypotheses in transgenic mouse models of human sickle cell disease: (1) Anti-inflammatory agents decrease vascular inflammation and improve blood flow. (2) Pro-inflammatory agents such as murine cytomegalovirus, lipopolysaccharide and hypoxia/reoxygenation, increase vascular inflammation and worsen vaso-occlusion. (3) TNF-alpha, IL-1 beta and CD18 transgenic knockout mice that express human betaS hemoglobin have decreased vascular inflammation and improved blood flow parameters. These studies will provide information for understanding the role of the inflammatory response and its relationship to vaso-occlusion in sickle cell disease and serve as an important foundation for developing new and novel therapies to prevent organ dysfunction.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
3R01HL067367-03S1
Application #
6798920
Study Section
Hematology Subcommittee 2 (HEM)
Program Officer
Evans, Gregory
Project Start
2001-04-01
Project End
2005-03-31
Budget Start
2003-04-01
Budget End
2004-03-31
Support Year
3
Fiscal Year
2003
Total Cost
$5,683
Indirect Cost
Name
University of Minnesota Twin Cities
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
555917996
City
Minneapolis
State
MN
Country
United States
Zip Code
55455
Vercellotti, Gregory M; Moldow, Charles F; Jacob, Harry S (2012) Complement, oxidants, and endothelial injury: how a bedside observation opened a door to vascular biology. J Clin Invest 122:3044-5
Beckman, Joan D; Chen, Chunseng; Nguyen, Julia et al. (2011) Regulation of heme oxygenase-1 protein expression by miR-377 in combination with miR-217. J Biol Chem 286:3194-202
Belcher, John D; Beckman, Joan D; Balla, Gyorgy et al. (2010) Heme degradation and vascular injury. Antioxid Redox Signal 12:233-48
Belcher, John D; Vineyard, Julie V; Bruzzone, Carol M et al. (2010) Heme oxygenase-1 gene delivery by Sleeping Beauty inhibits vascular stasis in a murine model of sickle cell disease. J Mol Med (Berl) 88:665-75
Nagy, Emoke; Eaton, John W; Jeney, Viktória et al. (2010) Red cells, hemoglobin, heme, iron, and atherogenesis. Arterioscler Thromb Vasc Biol 30:1347-53
Jeney, Viktória; Komódi, Edina; Nagy, Emõke et al. (2009) Supression of hemin-mediated oxidation of low-density lipoprotein and subsequent endothelial reactions by hydrogen sulfide (H(2)S). Free Radic Biol Med 46:616-23
Beckman, Joan D; Belcher, John D; Vineyard, Julie V et al. (2009) Inhaled carbon monoxide reduces leukocytosis in a murine model of sickle cell disease. Am J Physiol Heart Circ Physiol 297:H1243-53
Bruzzone, Carol M; Belcher, John D; Schuld, Nathan J et al. (2008) Quantitative real-time polymerase chain reaction (qRT-PCR) restriction fragment length polymorphism (RFLP) method for monitoring highly conserved transgene expression during gene therapy. Transl Res 152:290-7
Belcher, John D; Mahaseth, Hemachandra; Welch, Thomas E et al. (2006) Heme oxygenase-1 is a modulator of inflammation and vaso-occlusion in transgenic sickle mice. J Clin Invest 116:808-16
Belcher, John D; Mahaseth, Hemchandra; Welch, Thomas E et al. (2005) Critical role of endothelial cell activation in hypoxia-induced vasoocclusion in transgenic sickle mice. Am J Physiol Heart Circ Physiol 288:H2715-25

Showing the most recent 10 out of 12 publications